Exact Mass: 466.3658
Exact Mass Matches: 466.3658
Found 355 metabolites which its exact mass value is equals to given mass value 466.3658
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vitamin K1 2,3-epoxide
Vitamin K1 2,3-epoxide (CAS: 25486-55-9) is a vitamin K derivative. Vitamin K is needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, vitamin K undergoes electron reduction to a reduced form of vitamin K (called vitamin K hydroquinone) by the enzyme vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes vitamin K hydroquinone to allow carboxylation of glutamate into gamma-carboxyglutamate (Gla). This enzyme is called the gamma-glutamyl carboxylase or the vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize vitamin K hydroquinone into vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted into vitamin K by the vitamin K epoxide reductase. These two enzymes comprise the so-called vitamin K cycle. One of the reasons why vitamin K is rarely deficient in a human diet is because vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency (PMID: 12384421). Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of the coumarin-like activity of drugs (PMID: 2401753). Vitamin K1 2,3-epoxide is a vitamin K derivative. Vitamin K needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, Vitamin K undergoes electron reduction to a reduced form of Vitamin K (called Vitamin K hydroquinone) by the enzyme Vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes Vitamin K hydroquinone to allow carboxylation of Glutamate to Gamma-cabroxygluatmate (Gla); this enzyme is called the gamma-glutamyl carboxylase or the Vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize Vitamin K hydroquinone to vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted to Vitamin K by the Vitamin K epoxide reductase. These two enzymes comprise the so-called Vitamin K cycle. One of the reasons why Vitamin K is rarely deficient in a human diet is because Vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency. (PMID 12384421) Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of coumarin-like activity of drugs. (PMID 2401753) [HMDB]
ST 28:0;O5
A brassinosteroid that is castasterone in which the oxo group at position 6 has been converted to a hydroxy group (the 6alpha-stereoisomer).
omega-Hydroxyphylloquinone
LysoSM(d18:0)
Sphingomyelin (d18:0/0:0) or LysoSM(d18:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase. Sphingomyelin (d18:0/0:0) or LysoSM(d18:0)is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction.
N-Linoleoyl Tryptophan
N-linoleoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
2,3-Epoxyphylloquinone
Vitamin K1 2,3-epoxide is a vitamin K derivative. Vitamin K needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, Vitamin K undergoes electron reduction to a reduced form of Vitamin K (called Vitamin K hydroquinone) by the enzyme Vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes Vitamin K hydroquinone to allow carboxylation of Glutamate to Gamma-cabroxygluatmate (Gla); this enzyme is called the gamma-glutamyl carboxylase or the Vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize Vitamin K hydroquinone to vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted to Vitamin K by the Vitamin K epoxide reductase. These two enzymes comprise the so-called Vitamin K cycle. One of the reasons why Vitamin K is rarely deficient in a human diet is because Vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency. (PMID 12384421) Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of coumarin-like activity of drugs. (PMID 2401753) [HMDB]
Cholesterol phosphate
28-Norbrassinolide
28-norbrassinolide belongs to brassinolides and derivatives class of compounds. Those are cholestane based steroid lactones containing benzo[c]indeno[5,4-e]oxepin-3-one. 28-norbrassinolide is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 28-norbrassinolide can be found in tea and turnip, which makes 28-norbrassinolide a potential biomarker for the consumption of these food products.
6alpha-hydroxy-castasterone
6alpha-hydroxy-castasterone belongs to pentahydroxy bile acids, alcohols and derivatives class of compounds. Those are bile acids, alcohols or derivatives bearing five hydroxyl groups. 6alpha-hydroxy-castasterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6alpha-hydroxy-castasterone can be found in a number of food items such as common salsify, chicory roots, muscadine grape, and ginseng, which makes 6alpha-hydroxy-castasterone a potential biomarker for the consumption of these food products.
gigantursenyl acetate A|urs-18beta-H-12,20(30)-dien-3beta-yl acetate
(3alpha,5beta,7alpha,12alpha)-form-3,7,12,27-Tetrahydroxycholesten-26-oic acid
calotroplupenyl acetate A|lup-13(18),19(29)-dien-9alpha-yl acetate
(24S)-3beta,4beta,6alpha,8,24-pentahydroxy-5alpha-cholestan-15-one|certonardosterol Q2
24-Methylen-3-oxo-lanosta-7,9(11)-dien-21-saeure|3-oxo-eburica-7,9(11),24(28)-trien-21-oic acid|3-Oxo-eburica-7,9(11),24(28)-trien-21-saeure|7.11-Didehydro-eburiconsaeure|dehydroeburicoic acid|dehydroeburiconic acid
4alpha-methyl-5alpha-stigmasta-8,14,Z-24(28)-trien-3beta-yl acetate|4alpha-Methylvernosterol acetate
3beta-acetoxy-swerta-7,9(11)-diene|3beta-acetoxyswerta-7,9(11)-diene
(3beta, 5alpha, 6alpha, 24E)-Cholest-24-ene-3, 6, 8, 14, 15, 26-hexol, 9CI
calotropursenyl acetate|urs-12,19(29)-dien-3beta-yl acetate
3beta-Acetoxylupa-12,20(30)-dien|Dehydrolupeol-acetat|Delta-12,13 lupeol acetate
(24S)-24-methylcholestane-1beta,3beta,5alpha,6beta,25-pentol
(E)-N-[(20S)-20-(dimethylamino)-2beta-hydroxy-5alpha-pregnane-3beta-yl]benzamide|2beta-hydroxyepipachysamine D|2beta-hydroxyepipachysamine-D
(-)-duryne C
An enyne that is (4E,11Z,17Z,28E)-dotriaconta-4,11,17,28-tetraene-1,31-diyne substituted by hydroxy groups at positions 3 and 30 (the 3R,30R-stereoisomer). It has been isolated from the marine sponge Petrosia.
peruvianursenyl acetate B|ursa-5,12-dien-18alphaH-3beta-yl acetate
(24S)-ergostane-3beta,5alpha,6beta,11alpha-tetraol
balansinone|rel-(8S,9S,11R,13R,14S,17R,20S,22R,24S)-22-hydroxy-9,11-epoxy-24-methyl-9(10?19)abeo-lanost-25(10),25-trien-1-one
O-3-(beta-methyl)valeroyl alpha-bisabolol beta-D-fucopyranoside
(23R,24S)-3beta,11alpha,16beta,23,24-pentahydroxy-5alpha-cholestan-6-one
2-(3-eicosadienoyloxy-2-hydroxypropanoxy)methylpropenoic acid
(2alpha, 3beta, 5alpha, 6beta, 9alpha, 11alpha)-Cholest-7-ene-2, 3, 5, 6, 9, 11-hexol
2beta,3beta,14,20,22,25-hexahydroxy-5-cholest-7-ene
(24S)-ergostane-3beta,5alpha,6beta,7beta,15beta-pentol
(24S)-24-methyl-5alpha-cholestane-3beta,5,6beta,25xi,26-pentol|(24S)-24-methylcholestane-3beta,5alpha,6beta,25xi,26-pentol
lupa-5,20(29)-dien-3beta-yl acetate|lupedienyl acetate
(22E,24R)-5alpha-cholest-22-ene-3beta,4beta,6alpha,8,15beta,24-hexaol
(4aR)-10c-Acetoxy-2.2.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH)-Delta13.14a-octadecahydro-picen|3-Ac-3beta-11,13(18)-Oleanadien-3-ol|3beta-Acetoxy-oleana-11,13(18)-dien|3beta-acetoxy-oleana-11,13(18)-diene|3beta-Acetoxyolean-11,13(18)-diene|3beta-acetoxyolean-11,13-diene|Olean-11,13(18)-diene-3??-yl acetate|oleana-11,13(18)-dien-3beta-yl acetate|Oleana-11,13(18)-dienyl-3beta-acetat|oleana-11:13(18)-dien-3beta-yl acetate
3-Ac-3beta-9(11),12-Oleanadien-3-ol|3-acetoxyolean-9,12-dien|3beta-acetoxy-olean-9(11),12-diene|3beta-acetoxy-olean-9,12-diene|3beta-Acetoxyolean-9(11),12-diene|acetic acid oleana-9(11),12-dien-3beta-yl ester|olean-9(11),12(13)-dien-3beta-yl acetate|oleana-9(11),12-dien-3-yl acetate|oleana-9(11):12-dien-3beta-yl acetate
(6R)-2-(hydroxymethyl)-6-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(6R)-2-methyl-6-((2R,3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-2,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(2S,3R,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(2R,3R,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(2S,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(2R,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
4-Apo-3,4-didehydrolycopene/ (4-Apo-3,4-didehydrolycopene)
24,24-difluoro-1α,25-dihydroxy-24a-homovitamin D3 / 24,24-difluoro-1α,25-dihydroxy-24a-homocholecalciferol
(5Z,7E,17Z)-(1S,3R)-26,27-dimethyl-24a,24b-dihomo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol
2β,3α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid
3α,7α,12α,22-Tetrahydroxy-5β-cholestan-26-oic acid
3α,7α,12α,24-Tetrahydroxy-5α-cholestan-26-oic acid
3α,7α,12α,23-Tetrahydroxy-5β-cholestan-26-oic acid
1β,3α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid
3α,6α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid
3α,7α,12α,25-Tetrahydroxy-5β-cholestan-26-oic acid
2beta,3alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,22-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,24-Tetrahydroxy-5alpha-cholestan-26-oic acid
3alpha,7alpha,12alpha,23-Tetrahydroxy-5beta-cholestan-26-oic acid
1beta,3alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,6alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,25-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,22S-trihydroxy-5alpha-cholestan-26-oic acid
3alpha,7alpha,12alpha,26-tetrahydroxy-5alpha-cholestan-27-oic acid
(25R)-1beta,3alpha,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oic acid
(25S)-2beta,3alpha,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,22S-tetrahydroxy-5beta-cholestan-26-oic acid
(25S)-3alpha,7alpha,12alpha,24R-tetrahydroxy-5beta-cholestan-26-oic acid
(25R)-3alpha,7alpha,12alpha,24R-tetrahydroxy-5beta-cholestan-26-oic acid
(25S)-3alpha,7alpha,12alpha,24S-tetrahydroxy-5beta-cholestan-26-oic acid
(25R)-3alpha,7alpha,12alpha,24S-tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestan-27-oic acid
3alpha,7alpha,15alpha,22S-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,16alpha,22S-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,16alpha,24R-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,16alpha-Tetrahydroxy-5beta-cholestan-26-oic acid
24,24-difluoro-1alpha,25-dihydroxy-24a-homovitamin D3
(17Z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomovitamin D3
2,3-epoxyphylloquinone
U-73343
U-73343, works as a protonophore, is an inactive analog of U-73122 and can be used as a negative control. U-73343 dose-dependently inhibits acid secretion irrespective of the stimulant. U-73122 is a phospholipase C (PLC) and 5-LO (5-lipoxygenase) inhibitor with an IC50 of 1-2.1 μM for PLC[1][2].
3,7,11,18,22,26-hexaazatricyclo-{26.2.2.2(13,16)}tetratriaconta-1(31),13(33),14,16(34),28(32),29-hexaene
(TRANS,TRANS)-4-PROPYL[1,1-BICYCLOHEXYL]-4-CARBOXYLIC ACID-4- (TRANS-4-BUTYLCYCLOHEXYL)PHENYL ESTER
6alpha-hydroxy-castasterone
6alpha-hydroxy-castasterone belongs to pentahydroxy bile acids, alcohols and derivatives class of compounds. Those are bile acids, alcohols or derivatives bearing five hydroxyl groups. 6alpha-hydroxy-castasterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6alpha-hydroxy-castasterone can be found in a number of food items such as common salsify, chicory roots, muscadine grape, and ginseng, which makes 6alpha-hydroxy-castasterone a potential biomarker for the consumption of these food products. 6α-hydroxy-castasterone belongs to pentahydroxy bile acids, alcohols and derivatives class of compounds. Those are bile acids, alcohols or derivatives bearing five hydroxyl groups. 6α-hydroxy-castasterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6α-hydroxy-castasterone can be found in a number of food items such as common salsify, chicory roots, muscadine grape, and ginseng, which makes 6α-hydroxy-castasterone a potential biomarker for the consumption of these food products.
[3-carboxy-2-[(8E,11E,13E)-15-hydroxyicosa-8,11,13-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(9E,11E,14E)-8-hydroxyicosa-9,11,14-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(5E,8E,11E)-3-hydroxyicosa-5,8,11-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(8E,11E,14E)-3-hydroxyicosa-8,11,14-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(8E,11E)-henicosa-8,11-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(11E,14E)-henicosa-11,14-dienoyl]oxypropyl]-trimethylazanium
[3-Carboxy-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[11-(3,4-dimethyl-5-propylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[7-(5-heptyl-3,4-dimethylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[9-(5-hexyl-3-methylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium
N-[3-(3,5-dimethyl-1-piperidinyl)propyl]-1-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methyl]-4-piperidinecarboxamide
(24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oic acid
(2S,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(6R)-2-methyl-6-((2R,3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-2,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(24S)-3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-oic acid with S configuration at C-24.
2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-pentadec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
[17-[(E)-5,6-dimethylhept-3-en-2-yl]-4,4,10,13-tetramethyl-1,2,3,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate
(1-hydroxy-3-octoxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
[3-Hydroxy-2-(octanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] hexanoate
(1-hydroxy-3-nonoxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] acetate
[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] heptanoate
[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] octanoate
[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] nonanoate
[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] butanoate
[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] pentanoate
[3-Hydroxy-2-(propanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate
[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] decanoate
(2-Acetamido-3-hydroxypentadecyl) 2-(trimethylazaniumyl)ethyl phosphate
[2-(Butanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
[3-Hydroxy-2-(pentanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-carboxy-2-[(9E,11E)-henicosa-9,11-dienoyl]oxypropyl]-trimethylazanium
2,3-dihydroxypropyl (15Z,18Z)-hexacosa-15,18-dienoate
(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
[3-Hydroxy-2-(nonanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate
(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoic acid
(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(2R,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(1-butanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
(1-hexanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
(1-hydroxy-3-propanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
[1-carboxy-3-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[(2S)-2,3-dihydroxypropyl] (5E,9E)-hexacosa-5,9-dienoate
[1-carboxy-3-[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
2-[hydroxy-[2-hydroxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
Sphinganine-1-phosphocholine
A phosphosphingolipid consisting of sphinganine having a phosphocholine group attached to its primary hydroxyl group.
3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oic acid
(1r,5as,6s,7s,9as,11ar)-1-[(2r,5z)-5-isopropylhept-5-en-2-yl]-6,9a,11a-trimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(1r,3r,3as,3bs,5s,5as,6r,7s,9as,9br,11ar)-1-[(2r,3e,5s)-7-hydroxy-5-methylhept-3-en-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol
4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a-dodecahydropicen-3-yl acetate
(1s,5r,7r)-1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
3b,5,6,7-tetrahydroxy-1-(5-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-3-one
1-(6,7-dihydroxy-5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol
(1r,3r,3as,3br,5s,5as,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,7-triol
n-[(1s,3as,3br,5as,7r,8s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]benzenecarboximidic acid
(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid
2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid
(4as,6ar,6bs,13bs,15ar,15bs)-4,4,6a,8a,13b,15b-hexamethyl-1h,2h,3h,4ah,5h,6h,6bh,7h,8h,13h,13ah,14h,15h,15ah-indeno[2,1-a]chrysene-9,10,12-triol
n-{1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}benzenecarboximidic acid
1-(6-hydroxy-5-methylhept-3-en-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol
11,13(18)-oleanadien-3-ol; 3β-form,3-ac
{"Ingredient_id": "HBIN000260","Ingredient_name": "11,13(18)-oleanadien-3-ol; 3\u03b2-form,3-ac","Alias": "NA","Ingredient_formula": "C32H50O2","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "2118-75-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9415","PubChem_id": "NA","DrugBank_id": "NA"}